Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Wnt and Notch signaling help wound healing by promoting cell growth and regulating cell differentiation.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Targeting regulatory T cells may help treat age-related diseases.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.